Control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in a French national study (Phenomen)

Achievement of Cardiometabolic Goals among Diabetic Patients in Spain. A Nationwide Population-Based Study

“…The percentage of use of ACE inhibitors or ARBs in aware diabetic persons with known hypertension in our study was relatively low (58.8%) considering that, according to recommendations [2], [4] all such persons should receive hypertensive treatment with one drug from this group. Our data are similar to those of the U.S. [24] and much lower than the levels of use of ACE inhibitors or ARBs in hypertensive diabetics in France (82%) [25]. The use of statins in persons who require this treatment due to their cardiovascular risk or LDL levels follows the same pattern, far below the ADA recommendations and lower than found in other studies [19].…”

Introduction: avancées récentes dans la prévention des maladies cardiovasculaires chez le patient diabétique

“…They also confirm the wide gap between recommended targets for blood pressure, blood glucose and cholesterol and the levels actually achieved in clinical practice [2]. In turn they describe data from the 'Forlife' study in Italy [3] and the 'Phenomen' study in France [4], documenting the high levels of both microvascular and macrovascular disease. Between one quarter and one third of patients with type 2 diabetes have well-documented renal disease and similar proportions have experienced a coronary event [2][3][4].…”

“…In turn they describe data from the 'Forlife' study in Italy [3] and the 'Phenomen' study in France [4], documenting the high levels of both microvascular and macrovascular disease. Between one quarter and one third of patients with type 2 diabetes have well-documented renal disease and similar proportions have experienced a coronary event [2][3][4]. These findings have recently been confirmed in another Italian survey, the IPERDIA study [5], showing that type 2 diabetes is three times more prevalent among individuals with hypertension than in the general population and is associated with a high prevalence of cardiovascular disorders.…”

A multinational, multi‐centre, observational, cross‐sectional survey assessing diabetes secondary care in Central and Eastern Europe (DEPAC Survey)

“…[10] reported that 13% of T2D patients achieved a target blood pressure of 130/80 mmHg and, in a French nationwide T2D survey, mean BP was 140/80 mmHg, with 29% of patients meeting the slightly higher target BP < 140/80 mmHg [12]. In another French study, only 0.3% of T2D patients reached all three World Health Organization (WHO) targets in plasma lipids, HbA 1c and BP [13]. In an Italian study, 74% of T2D patients had systolic BP > 130 mmHg [14].…”